Navigation Links
A cost effective heart failure drug hits the market!

With sky high health-care costs it has become a burden both on the body as well as the purse if sickness strikes. But as a respite comes a new cardio drug that negates both the above said effects of ill health. //

The drug is in the African-American heart failure patients where it has greatly improved the condition.

Derek Angus, M.D., M.P.H., professor of critical care medicine at the University Of Pittsburgh School Of Medicine led the study where in he examined data from the African-American Heart Failure Trial (A-HeFT) study in order to determine the trial participants' ongoing health care costs. The comparison was made in patients who took a medication with two active drug ingredients, isosorbide dinitrate and hydralazine (ISDN/HYD), to those in patients receiving a placebo regimen. The trial demonstrated the effectiveness of ISDN/HYD for treating heart failure in African-American patients.

The result demonstrated that total health care costs for the AHeFT participants who were treated with ISDN/HYD were 22 percent lower. Health care costs specifically related to heart failure were almost 34 percent lower on average, $5,997 versus $9,144. When the cost of the drug was factored in, there was still an average savings of 6 percent, or $533, on heart failure-related costs for ISDN/HYD patients compared to those who didn't receive the drug, and a 9 percent, or $1,730, average savings on total health care costs.

As stated by Dr. Angus, "This medication clearly decreased healthcare costs for AHeFT participants during the course of the clinical trial, even when the cost of the drug itself was taken into account. Based on the savings we've seen for one year and our modelling that projects future health care cost expenditures, it's likely that the cost-effectiveness of this drug will bear out in the long term as well."

Dr. Angus and his colleagues developed a model to predict costs over the course of the pa
'"/>




Page: 1 2

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. An effective drug for lung cancer
11. Naltrexone effective for drinking problems
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
... new genes which are active in prostate cancer hav...r level, cancer tissue differs markedly from norma...Researchers have now developed the tools that can ...that characterise the cancerous cell. Using microa...
...rican doctors are using a computer to do a double ...egular mammogram tests to check for early breast c...e. Researchers at the Sloan-Kettering Cancer Resea...d detection (CAD) to help analyse lesions that a f...
...ple living with smokers have a relatively poor die...ng. It has been estimated that second-hand smoke a.... Where people are exposed to passive smoking - us...or work in a smoky environment - a healthy diet mi...
...nking hot tea with lemon peel could protect the bo...earchers studied 470 people, half of whom had suff...d them about their tea-drinking habits.// They fo...ncer drank significantly less hot tea.Lemon peel i...
Other Medicine News:
(Date:8/14/2008)...all/ -- Pharmasset, Inc.,(Nasdaq: VRUS ), a clini...overing, developing and commercializing novel drug...nancial results for the third fiscal,quarter ended...ributable to,common stockholders of $15.0 million,...d June 30, 2008, as compared to a net loss attribu...
(Date:8/14/2008)...nable Targeting and Increase Spee.... and HEIDELBERG, Germany, Aug. 14 /-...titute (TGen) today announced,the formation of a c...ration-Sequencing equipment in conjunction with fe..., febit,s HybSelect(TM) Technology enables select...
(Date:8/13/2008)...As biotechnology,pharmaceutical and medical devic...nd their own borders to other parts of the world, ...mplicated regulatory environments,challenge those ...lysis by,Aon Corporation (NYSE: AOC ). Aon,s 2008... a visual representation of the complex insurance,...
(Date:8/13/2008)... to automatically measure QT inter...lif., Aug. 13 /- NewCardio,...stic and services company, today,revealed the resu...no(TM),(the "NCE3 Study"). The study was led by an...t with extensive experience in pharmaceutical clin...
Breaking Medicine Technology:Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9febit and TGen Collaborate to Study New DNA Capture Method 2febit and TGen Collaborate to Study New DNA Capture Method 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 2Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 3Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders 4NewCardio Announces Positive Results From Third Clinical Validation Study 2NewCardio Announces Positive Results From Third Clinical Validation Study 3NewCardio Announces Positive Results From Third Clinical Validation Study 4NewCardio Announces Positive Results From Third Clinical Validation Study 5Molecular alliance that sustains embryonic stem cell state 13467 1Molecular alliance that sustains embryonic stem cell state 13467 2Molecular alliance that sustains embryonic stem cell state 13467 3Non Polyp Colon Lesions Hard to Detect 13462 1Non Polyp Colon Lesions Hard to Detect 13462 2Non Polyp Colon Lesions Hard to Detect 13462 3Sticky blood protein yields clues to autism 13458 1Sticky blood protein yields clues to autism 13458 2Sticky blood protein yields clues to autism 13458 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2
...t Study in American Heart Journal , ,WINNIPEG, Ma...mex:MCU), a cardiovascular focused, biopharmaceuti...llow-up results from the,STRATEGY (Single High-Dos...us Abciximab and Bare Metal Stent In Acute Myocard...dition of the Journal,of the American College of C...
...1, 2007 /PRNewswire/ -- Phase 3 results,from the R...an,etexilate once daily, administered for an avera...o administered for an average of 33,days, in preve...ortality after total hip replacement surgery. In t...ith dabigatran etexilate was,similar to enoxaparin...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: